Ce contenu est réservé aux abonnés de la Revue Médicale Suisse.
Si votre login ne fonctionne pas, contactez-nous à commandes@medhyg.ch
La Revue Médicale Suisse est une revue hebdomadaire dédiée à la formation continue des médecins de premiers recours et spécialistes. L'abonnement donne accès à la revue en ligne et aux applications médicales.
1Barsky AJ, Cleary PD, Coeytaux RR, Ruskin JN. The clinical course of palpitations in medical outpatients. Arch Intern Med 1995 ; 155 : 1782-8.
2Barsky AJ, Delamater BA, Clancy SA, Antman EM, Ahern DK. Somatized psychiatric disorder presenting as palpitations. Arch Intern Med 1996 ; 156 : 1102-8.
3Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med 1996 ; 100 : 138.
4Sarasin FP, Carballo D, Slama S, Louis-Simonet M. Usefulness of 24-h Holter monitoring in patients with unexplained syncope and a high likelihood of arrhythmias. Int J Cardiol 2005 ; 101 : 203-7.
5Zehender M, Meinertz T, Faber T, Caspary A, Jeron A, Bremm K, Just H. Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators. J Am Coll Cardiol 1997 ; 29 : 1028-34.
6Barsky AJ, Cleary PD, Coeytaux RR, Ruskin JN. Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Intern Med 1994 ; 9 : 306-13.
7Pratt CM, Camm AJ, Cooper W, Friedman PL, MacNeil DJ, Moulton KM, Pitt B, Schwartz PJ, Veltri EP, Waldo AL. Mortality in the Survival With Oral D-sotalol (SWORD) trial : why did patients die ? Am J Cardiol 1998 ; 81 : 869-76.
8Preliminary report : Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. New Engl J Med 1989 ; 10 : 406-12.
9Sivakumaran S, Krahn AD, Klein GJ, et al. A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. Am J Med 2003 ; 115 : 1-5.
10 Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med 1999 ; 130 : 848-56.
11Mayou R, Sprigings D, Birkhead J, Price J. Characteristics of patients presenting to a cardiac clinic with palpitation. QJM 2003 ; 96 : 115-23.
12Zeldis SM, Levine BJ, Michelson EL, Morganroth J. Cardiovascular complaints. Correlation with cardiac arrhythmias on 24-hour electrocardiographic monitoring. Chest 1980 ; 78 : 456-61.
13 Levy S, Olshansky B. Arrythmia management for the primary care clinician. Uptodate 2000, www.uptodate.com
14Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure : Meta-analysis of individual data from 6’500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. Lancet 1997 ; 350 : 1417-24.
15Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985 ; 312 : 193-7.
16Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Europace. 2006 ; 8 : 651-745.
17Theroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala HF. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979 ; 301 : 341-5.